These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2332628

  • 1. Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2.
    Chen W, Reese VA, Cheever MA.
    J Immunol; 1990 May 15; 144(10):3659-66. PubMed ID: 2332628
    [Abstract] [Full Text] [Related]

  • 2. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression.
    Chen W, Cheever MA.
    J Immunol; 1994 May 15; 152(10):4767-74. PubMed ID: 8176202
    [Abstract] [Full Text] [Related]

  • 3. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W, Schweins E, Chen X, Finn OJ, Cheever MA.
    J Immunol; 1994 Oct 15; 153(8):3630-8. PubMed ID: 7930583
    [Abstract] [Full Text] [Related]

  • 4. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP, Matis LA, Kern DE, Mizuno MT, Peace DJ, Thompson JA, Greenberg PD, Cheever MA.
    J Immunol; 1987 Jun 01; 138(11):4012-7. PubMed ID: 3108381
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo.
    Cheever MA, Thompson JA, Kern DE, Greenberg PD.
    J Biol Response Mod; 1984 Oct 01; 3(5):462-7. PubMed ID: 6334133
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA, Greenberg PD, Irle C, Thompson JA, Urdal DL, Mochizuki DY, Henney CS, Gillis S.
    J Immunol; 1984 May 01; 132(5):2259-65. PubMed ID: 6609193
    [Abstract] [Full Text] [Related]

  • 7. T-cells for tumor therapy can be obtained from antigen-loaded sponge implants.
    Chen W, Reese VA, Cheever MA.
    Cancer Res; 1994 Feb 15; 54(4):1065-70. PubMed ID: 8313363
    [Abstract] [Full Text] [Related]

  • 8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA, Ruscetti SK, Longo DL, Jacobson S, Brown EJ, Zinn S, Kruisbeek AM.
    J Immunol; 1985 Jul 15; 135(1):703-13. PubMed ID: 2582053
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB, Holden HT, Ting CC, Lavrin DL, Kirchner H.
    Cancer Res; 1976 Feb 15; 36(2 pt 2):615-21. PubMed ID: 56223
    [Abstract] [Full Text] [Related]

  • 10. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD, Cheever MA.
    J Immunol; 1984 Dec 15; 133(6):3401-7. PubMed ID: 6149246
    [Abstract] [Full Text] [Related]

  • 11. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K, Pellis NR, Kahan BD.
    Cancer Res; 1988 Jan 01; 48(1):101-8. PubMed ID: 3257158
    [Abstract] [Full Text] [Related]

  • 12. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
    Kern DE, Peace DJ, Klarnet JP, Cheever MA, Greenberg PD.
    J Immunol; 1988 Oct 15; 141(8):2824-30. PubMed ID: 2459230
    [Abstract] [Full Text] [Related]

  • 13. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 14. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ, Rosenstein M, Spiess PJ, Rosenberg SA.
    J Natl Cancer Inst; 1982 Jul 15; 69(1):109-16. PubMed ID: 6980314
    [Abstract] [Full Text] [Related]

  • 15. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 16. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA, Schlom J, Abrams SI.
    Cell Immunol; 1999 May 25; 194(1):78-89. PubMed ID: 10357883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

  • 19. Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.
    Matis LA, Shu S, Groves ES, Zinn S, Chou T, Kruisbeek AM, Rosenstein M, Rosenberg SA.
    J Immunol; 1986 May 01; 136(9):3496-501. PubMed ID: 2420893
    [Abstract] [Full Text] [Related]

  • 20. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA, Peace DJ, Klarnet JP, Kern DE, Greenberg PD, Cheever MA.
    J Immunol; 1986 Dec 01; 137(11):3675-80. PubMed ID: 3491145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.